5 Things to Know Before the Stock Market Opens on Thursday

Stock futures point to a mixed open after the Dow notched another record close, but selling pressure is rising as SpaceX’s first lock-up period expires and more shares hit the market. Western Digital/SanDisk shares are tumbling on weaker quarterly results, while Honeywell Aerospace drops following a lackluster earnings report. Moderna is the outlier, rallying after FDA approval for its mRNA-based flu shot.

Analysis

The memory print looks like a pricing/turns issue, not a one-off earnings miss. WDC and SNDK are the more fragile names because NAND-heavy balance sheets can feel spot-price weakness faster than the rest of semis, while the real second-order loser is any supplier chain exposed to delayed OEM orders and slower inventory rebuilds; that matters more over the next 1-3 months than today’s open. The contrarian read is that this is not automatically a broad-semiconductor tell: if DRAM/AI demand remains intact, the damage should stay concentrated in storage, which favors relative longs in broader-memory leaders versus the weakest storage names.

Honeywell Aerospace weakness is more about multiple risk than earnings collapse. When a quality industrial misses in a subsegment the market thought was “safe,” the next leg is usually valuation compression before fundamental cuts show up; that argues for a 1-2 quarter window of underperformance unless aftermarket growth re-accelerates. If backlog stays stable, this may be a buyable dip for long-only, but the burden of proof is now on the company to show margin resilience rather than just revenue growth.

Moderna’s FDA win is meaningful as platform validation, but it is not yet an earnings inflection because the market still needs proof of commercial uptake and pricing power in a crowded flu market. The Street may be capitalizing optionality too early; the catalyst path is 1-3 months of launch/distribution commentary, with the real P&L test in next flu season. SpaceX’s lock-up expiry is mostly a sentiment and comp issue: it can pressure late-stage space/private-tech marks and narrow financing windows for public proxies, but that’s a weeks-to-months flow story, not an immediate index driver.

Key Decisions for Investors

• Short WDC/SNDK on any opening bounce or via 4-8 week put spreads; target 10-15% downside if NAND pricing and inventory commentary stay weak. Falsifier: evidence of pricing stabilization or an order inflection in the next channel checks.
• Relative-value: long MU vs short WDC/SNDK basket for 1-3 months to isolate storage-specific weakness from broader memory strength. Falsifier: Micron commentary confirms DRAM softness or AI capex slows enough to drag the whole group.
• Fade the HONA dip only after the next guidance update; until then prefer short HONA vs RTX/LMT on a 1-2 quarter horizon if aftermarket/margin commentary remains soft. Falsifier: management reaffirms margin expansion and raises full-year aerospace outlook.
• Do not chase MRNA strength immediately; use a retrace to initiate a small call spread only if launch/timing details are confirmed, otherwise treat the approval as a sentiment catalyst rather than an earnings event. Falsifier: weak commercial uptake or delayed launch economics.